BR112015015229A8 - processo para a preparação de um composto da fórmula, e, composto - Google Patents
processo para a preparação de um composto da fórmula, e, composto Download PDFInfo
- Publication number
- BR112015015229A8 BR112015015229A8 BR112015015229A BR112015015229A BR112015015229A8 BR 112015015229 A8 BR112015015229 A8 BR 112015015229A8 BR 112015015229 A BR112015015229 A BR 112015015229A BR 112015015229 A BR112015015229 A BR 112015015229A BR 112015015229 A8 BR112015015229 A8 BR 112015015229A8
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- formula
- preparation
- present
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
processo para a preparação de um composto da fórmula, e, composto a presente invenção refere-se a um novo processo para a preparação da fórmula (i), em que r1 e r2 são aqui descritos. os compostos preparados pela presente invenção são utilizáveis na síntese e fabricação de compostos para tratar doenças ou condições associadas com a inibição da polimerização da actina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012087380 | 2012-12-25 | ||
| CNPCT/CN2012/087380 | 2012-12-25 | ||
| PCT/EP2013/077563 WO2014102164A1 (en) | 2012-12-25 | 2013-12-20 | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112015015229A2 BR112015015229A2 (pt) | 2017-07-11 |
| BR112015015229A8 true BR112015015229A8 (pt) | 2019-10-15 |
| BR112015015229B1 BR112015015229B1 (pt) | 2020-07-07 |
Family
ID=49876646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015015229-5A BR112015015229B1 (pt) | 2012-12-25 | 2013-12-20 | processo para a preparação de um composto da fórmula, e, composto |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9388168B2 (pt) |
| EP (1) | EP2938609B1 (pt) |
| JP (1) | JP6297590B2 (pt) |
| KR (1) | KR102122569B1 (pt) |
| CN (1) | CN105051031B (pt) |
| AU (1) | AU2013369473B2 (pt) |
| BR (1) | BR112015015229B1 (pt) |
| CA (1) | CA2896155C (pt) |
| CY (1) | CY1119040T1 (pt) |
| DK (1) | DK2938609T3 (pt) |
| ES (1) | ES2629313T3 (pt) |
| HK (1) | HK1213262A1 (pt) |
| HR (1) | HRP20170653T1 (pt) |
| HU (1) | HUE032621T2 (pt) |
| IL (1) | IL239558A (pt) |
| LT (1) | LT2938609T (pt) |
| NZ (1) | NZ709362A (pt) |
| PL (1) | PL2938609T3 (pt) |
| PT (1) | PT2938609T (pt) |
| RU (1) | RU2621725C2 (pt) |
| SG (1) | SG11201504951TA (pt) |
| SI (1) | SI2938609T1 (pt) |
| WO (1) | WO2014102164A1 (pt) |
| ZA (1) | ZA201504601B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019007119A (es) | 2016-12-15 | 2020-01-21 | Hua Medicine (Shanghai) Ltd | Preparado oral del activador de glucocinasa y preparacion del mismo. |
| US11813274B2 (en) | 2020-04-22 | 2023-11-14 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
| AU2020443475A1 (en) * | 2020-04-22 | 2022-11-17 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
| CN111732543A (zh) * | 2020-08-14 | 2020-10-02 | 浙江鼎龙科技有限公司 | 一种4,5-二氨基-1-（2-羟乙基）吡唑硫酸盐的制备方法 |
| CN113750100B (zh) * | 2021-08-31 | 2022-12-30 | 海南中济医药科技有限公司 | 一种含有多扎格列艾汀与西格列汀的药物组合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4160841A (en) * | 1977-01-31 | 1979-07-10 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
| FR2748274B1 (fr) * | 1996-05-03 | 1998-06-12 | Oreal | Nouveaux diamino pyrazoles, leur synthese, compositions de teinture des fibres keratiniques les contenant, procede de teinture des fibres keratiniques |
| TW200942239A (en) | 2008-01-18 | 2009-10-16 | Astellas Pharma Inc | Phenylacetamide derivatives |
| US7741327B2 (en) * | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
| US8178689B2 (en) * | 2010-06-17 | 2012-05-15 | Hoffman-La Roche Inc. | Tricyclic compounds |
-
2013
- 2013-12-20 HU HUE13811542A patent/HUE032621T2/en unknown
- 2013-12-20 BR BR112015015229-5A patent/BR112015015229B1/pt active IP Right Grant
- 2013-12-20 PL PL13811542T patent/PL2938609T3/pl unknown
- 2013-12-20 SI SI201330684A patent/SI2938609T1/sl unknown
- 2013-12-20 RU RU2015126911A patent/RU2621725C2/ru active
- 2013-12-20 WO PCT/EP2013/077563 patent/WO2014102164A1/en active Application Filing
- 2013-12-20 US US14/655,287 patent/US9388168B2/en active Active
- 2013-12-20 NZ NZ709362A patent/NZ709362A/en unknown
- 2013-12-20 PT PT138115423T patent/PT2938609T/pt unknown
- 2013-12-20 KR KR1020157019691A patent/KR102122569B1/ko active IP Right Grant
- 2013-12-20 JP JP2015550041A patent/JP6297590B2/ja active Active
- 2013-12-20 LT LTEP13811542.3T patent/LT2938609T/lt unknown
- 2013-12-20 EP EP13811542.3A patent/EP2938609B1/en active Active
- 2013-12-20 CA CA2896155A patent/CA2896155C/en active Active
- 2013-12-20 DK DK13811542.3T patent/DK2938609T3/en active
- 2013-12-20 AU AU2013369473A patent/AU2013369473B2/en active Active
- 2013-12-20 SG SG11201504951TA patent/SG11201504951TA/en unknown
- 2013-12-20 ES ES13811542.3T patent/ES2629313T3/es active Active
- 2013-12-20 CN CN201380068179.8A patent/CN105051031B/zh active Active
-
2015
- 2015-06-21 IL IL239558A patent/IL239558A/en active IP Right Grant
- 2015-06-25 ZA ZA2015/04601A patent/ZA201504601B/en unknown
-
2016
- 2016-02-04 HK HK16101337.2A patent/HK1213262A1/zh unknown
-
2017
- 2017-04-27 HR HRP20170653TT patent/HRP20170653T1/hr unknown
- 2017-07-10 CY CY20171100727T patent/CY1119040T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013000920A2 (pt) | compostos para a redução de produção de beta-amiloide | |
| BR112014008186A2 (pt) | método para proteção de plantas úteis ou material de propagação de plantas | |
| BRPI0910388A2 (pt) | agentes terapêutico antivirais. | |
| BR112012019762A2 (pt) | composto, composição, e, método para tratar uma doença. | |
| BR112015008037A2 (pt) | compostos, processo para a preparação de um composto, composição farmacêutica, utilização do composto, método para o tratamento do câncer e invenção | |
| BR112017027831A2 (pt) | derivados de hidroxiácido, um processo para sua preparação e composições farmacêuticas contendo-os | |
| BRPI0813284A8 (pt) | Processo para a preparação de um composto da fórmula (i) e composto | |
| BR112012032244A2 (pt) | processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes | |
| CU24183B1 (es) | Derivados de ácido 3-fenilpropiónico ramificados | |
| BR112013018515A2 (pt) | derivados de pirrol tricíclico, processo para preparação e seu uso como inibidores da quinase | |
| CO6771439A2 (es) | Inhibidores de benzodioxano de la producción de leucotrieno | |
| BR112014008045A2 (pt) | benzilindazóis substituídos para uso como inibidores de bub1 cinase no tratamento de doenças hiperproliferativas | |
| BR112012006031A2 (pt) | processo para preparação de compostos azabicíclicos. | |
| BR112012007085B8 (pt) | processos para a preparação de derivados de benzil-benzeno substituídos com glicopiranosila | |
| BR112015031913A2 (pt) | processo para a fabricação de amino-benzoxazinonas 4-propargilatadas e sua utilização | |
| BR112015015229A8 (pt) | processo para a preparação de um composto da fórmula, e, composto | |
| BR112015008717A2 (pt) | composto, composição farmacêutica, método de tratar diabetes do tipo ii, uso do composto de fórmula (i), medicação para o tratamento de diabetes do tipo ii | |
| BRPI1014802B8 (pt) | profármacos de triptolida. | |
| BR112018006519A2 (pt) | compostos de fórmula, processo para a síntese de compostos, compostos intermediários x, composição, utilização de um composto de fórmula, método para o combate de fungos e semente | |
| BR112012023836A2 (pt) | composto tricíclicos e inibidores de pbk contendo os mesmos | |
| BR112013028486A2 (pt) | método para promover crescimento de planta | |
| BRPI0817747A8 (pt) | Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico | |
| BR122018074319B8 (pt) | Método para preparar um composto de fórmula 14 | |
| BR112015014583B1 (pt) | compostos, processo para a preparação de compostos, compostos intermediários, composição, usos de um composto de fórmula i e método para combater fungos nocivos | |
| BR112014004523A2 (pt) | composto e composição aromatizante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/12/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B25A | Requested transfer of rights approved |
Owner name: HUA MEDICINE (SHANGHAI) LTD. (CN) |